Sayre focuses on niche products and orphan medications,

in areas with a high unmet need. These include, but are not limited to, small molecules, recombinant proteins and monoclonal antibodies (mAbs) in Oncology and Immunology. We collaborate with diagnostic labs and partners to provide access to innovative molecular companion diagnostic products aimed at transforming patient care. In delivering therapeutic agents with improved efficacy and minimum side effects, novel drug delivery system (NDDS) play a big role. They offer patient convenience, safety and improved efficacy and is an area of focus for Sayre Therapeutics.